McKesson Corp (MCK) operating KPIs
MCKNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 16/3017% above fair value
$994.58+13.70 (+1.40%)
Close on Oct 30, 2026Market cap $115.96BP/E 26.6Yield 0.32%
KPIs
Operating metrics that drive McKesson's business
| Countries of operation | Q1 21 | Q3 20 | Q2 20 | Q1 20 | Q3 19 | Q2 19 | Q1 19 | YoY |
|---|---|---|---|---|---|---|---|---|
| European Pharmaceutical Solutions | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 0.0% |
Counts and sizes McKesson tags in the notes of its 10-K and 10-Q filings (XBRL), as of the end of each quarter. Breakdowns follow the company's own labels; at most 15 are shown per metric. A fuller KPI sheet built from earnings releases and presentations is on the way. See how companies compare on these metrics.